| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/12/2001 | WO2001025208A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 04/12/2001 | WO2001025207A1 Novel nicotinonitrile compounds |
| 04/12/2001 | WO2001025204A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | WO2001025200A1 Cyclic amine compounds as ccr5 antagonists |
| 04/12/2001 | WO2001025199A1 Urea compounds, process for producing the same and use thereof |
| 04/12/2001 | WO2001025190A1 Novel diarylamide derivatives and use thereof as medicines |
| 04/12/2001 | WO2001025189A1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds |
| 04/12/2001 | WO2001025188A1 Novel carbamates and ureas |
| 04/12/2001 | WO2001024828A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024827A2 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024824A1 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024814A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/12/2001 | WO2001024810A1 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions |
| 04/12/2001 | WO2001024802A1 Antiobestic agents |
| 04/12/2001 | WO2001024799A1 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, dna viruses and retroviruses |
| 04/12/2001 | WO2001024796A1 1,2,4-triazole derivatives, composition, process of making and methods of use |
| 04/12/2001 | WO2001024795A1 RETARD FORM CONTAINING α-LIPOIC ACID (DERIVATIVES) |
| 04/12/2001 | WO2001024792A1 Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog |
| 04/12/2001 | WO2001024791A1 Use of synergistic combinations of a nk1 receptor antagonist and a gaba analog in psychiatric disorders |
| 04/12/2001 | WO2001024790A1 Agents for relieving carbonyl stress |
| 04/12/2001 | WO2001024785A2 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
| 04/12/2001 | WO2001024784A2 New use |
| 04/12/2001 | WO2001024774A1 Ortho ester lipids |
| 04/12/2001 | WO2001024773A1 Liposome-entrapped dna oral vaccines |
| 04/12/2001 | WO2001024627A1 Animal with the mass expression of human gene and test method by using the animal |
| 04/12/2001 | WO2001005420A8 SMALL PEPTIDES AND METHODS FOR DOWNREGULATION OF IgE |
| 04/12/2001 | WO2001005382A8 Synergistic composition comprising daunorubicin derivatives and antimetabolite compounds |
| 04/12/2001 | WO2001000230A8 Drug composition containing lecithin-modified superoxide dismutase |
| 04/12/2001 | WO2000076958A3 Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 04/12/2001 | WO2000061755A3 Secreted human proteins |
| 04/12/2001 | WO1999067283A3 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 04/12/2001 | WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2 |
| 04/12/2001 | CA2699662A1 Rhodamine derivatives for photodynamic diagnosis, prevention and treatment of immunologic disorders |
| 04/12/2001 | CA2608807A1 Cyclic amine compounds as ccr5 antagonists |
| 04/12/2001 | CA2406882A1 Diagnostic probes and therapeutics targeting upa and upar |
| 04/12/2001 | CA2388864A1 Ortho ester lipids |
| 04/12/2001 | CA2388227A1 A human gene over-expressing animal and test methods using the animal |
| 04/12/2001 | CA2386546A1 Adeno-associated viruses and uses thereof |
| 04/12/2001 | CA2386540A1 Novel carbamates and ureas |
| 04/12/2001 | CA2386533A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 04/12/2001 | CA2386517A1 Amine derivatives |
| 04/12/2001 | CA2386499A1 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions |
| 04/12/2001 | CA2386465A1 Compositions and methods for tumor-targeted delivery of effector molecules |
| 04/12/2001 | CA2386457A1 Inhibitors of the endothelin signalling pathway and .alpha.v.beta.3 integrin receptor antagonists for combination therapy |
| 04/12/2001 | CA2386387A1 Urea compounds, their production and use |
| 04/12/2001 | CA2386383A1 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | CA2386239A1 Methods for identifying rna binding compounds |
| 04/12/2001 | CA2386236A1 Human inwardly rectifying potassium channel subunit |
| 04/12/2001 | CA2386228A1 Stabilized liquid pharmaceutical compositions comprising tissue factor pathway inhibitor (tfpi) polypeptides |
| 04/12/2001 | CA2386218A1 Triazine kinase inhibitors |
| 04/12/2001 | CA2386199A1 Endozepine-like polypeptides and polynucleotides encoding same |
| 04/12/2001 | CA2386147A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/12/2001 | CA2386089A1 Diagnostic and therapeutic epitope and transgenic plant |
| 04/12/2001 | CA2386036A1 Antiobesity agent |
| 04/12/2001 | CA2386024A1 Liposome-entrapped dna oral vaccines |
| 04/12/2001 | CA2385972A1 Novel diarylamide derivatives and use thereof as medicines |
| 04/12/2001 | CA2385930A1 Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog |
| 04/12/2001 | CA2385853A1 Design of high affinity rnase h recruiting oligonucleotide |
| 04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | CA2385251A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | CA2385244A1 Novel nicotinonitrile compounds |
| 04/12/2001 | CA2385210A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | CA2382691A1 Oxazinoquinolones useful for the treatment of viral infections |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/12/2001 | CA2351075A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/11/2001 | EP1090990A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090917A1 Quinolin-4-yl derivatives and their use as NMDA-receptor subtype blockers |
| 04/11/2001 | EP1090915A1 Polymorphic B form of 3-(cyclopropylmethoxy)-4-[-4-(methylsulfonyl)phenyl]- 5,5-dimethyl-5H-furan-2-one |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1090908A2 Cyclobutane derivatives as inhibitors of protein farnesyltransferase |
| 04/11/2001 | EP1090639A2 Pharmaceutical composition containing a progestational corticoid and a selective estrogen receptor modulator |
| 04/11/2001 | EP1090636A1 High lipid diet |
| 04/11/2001 | EP1090136A1 Mumbaistatin, a process for its production and its use as a pharmaceutical |
| 04/11/2001 | EP1090118A2 Human signal peptide-containing proteins |
| 04/11/2001 | EP1090116A2 Transgenic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 04/11/2001 | EP1090115A2 Modularly constructed rna molecules having two sequence region types |
| 04/11/2001 | EP1090112A1 Human arf-related proteins |
| 04/11/2001 | EP1090106A2 Alkylamines and their precursors as specific modulators of human gamma-delta t cell function |
| 04/11/2001 | EP1090105A1 Ependymal neural stem cells and method for their isolation |
| 04/11/2001 | EP1090104A1 Methods of expanding and selecting disease associated t-cells |
| 04/11/2001 | EP1090030A1 Compounds of unstable dipeptidyl peptidase iv inhibitors |
| 04/11/2001 | EP1090029A1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds |
| 04/11/2001 | EP1090028A1 Unsaturated 14,15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds |
| 04/11/2001 | EP1090022A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 04/11/2001 | EP1090021A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 04/11/2001 | EP1090012A1 Inhibitors of prenyl-protein transferase |
| 04/11/2001 | EP1090011A1 Inhibitors of prenyl-protein transferase |
| 04/11/2001 | EP1090010A1 Thienopyridine compounds, their production and use |
| 04/11/2001 | EP1090003A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones |
| 04/11/2001 | EP1089998A2 Epothilone derivatives and their synthesis and use |
| 04/11/2001 | EP1089997A1 4,5,6 and 7-indole and indoline derivatives, their preparation and use |
| 04/11/2001 | EP1089996A1 Paroxetine methanesulfonate |
| 04/11/2001 | EP1089994A1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 04/11/2001 | EP1089993A1 5-ht 1f? agonists |
| 04/11/2001 | EP1089981A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis. |
| 04/11/2001 | EP1089980A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 04/11/2001 | EP1089973A1 Amidino and guanidino azetidinone tryptase inhibitors |
| 04/11/2001 | EP1089969A1 Stable no-delivering compounds |